Coronado Biosciences Inc Share Price Nasdaq
Equities
US21976U1097
Pharmaceuticals
Sales 2024 * | 73.92M 5.85B | Sales 2025 * | 126M 9.96B | Capitalization | 34.9M 2.76B |
---|---|---|---|---|---|
Net income 2024 * | -89M -7.04B | Net income 2025 * | -75M -5.93B | EV / Sales 2024 * | 0.47 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.28 x |
P/E ratio 2024 * |
-0.36
x | P/E ratio 2025 * |
-0.53
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.59% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 68 | 30/09/09 | |
David Jin
DFI | Director of Finance/CFO | 34 | - |
Michael Weiss
BRD | Director/Board Member | 58 | 19/12/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 68 | 30/09/09 | |
Michael Weiss
BRD | Director/Board Member | 58 | 19/12/13 |
J. Lobell
BRD | Director/Board Member | 61 | 31/05/06 |
1st Jan change | Capi. | |
---|---|---|
+2.99% | 95.18B | |
-4.34% | 37.55B | |
-10.41% | 33.75B | |
+75.79% | 28.2B | |
-14.61% | 15.63B | |
-3.46% | 13.63B | |
-12.31% | 11.5B | |
+184.77% | 10.81B | |
-54.13% | 9.23B |